These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 29861191

  • 1. A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin.
    Rea WJ.
    Clin Ther; 2018 Jun; 40(6):889-893. PubMed ID: 29861191
    [Abstract] [Full Text] [Related]

  • 2. Effects of toxic exposure to molds and mycotoxins in building-related illnesses.
    Rea WJ, Didriksen N, Simon TR, Pan Y, Fenyves EJ, Griffiths B.
    Arch Environ Health; 2003 Jul; 58(7):399-405. PubMed ID: 15143852
    [Abstract] [Full Text] [Related]

  • 3. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
    Vojdani A, Kashanian A, Vojdani E, Campbell AW.
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):595-614. PubMed ID: 14686801
    [Abstract] [Full Text] [Related]

  • 4. Adverse human health effects associated with molds in the indoor environment.
    Hardin BD, Kelman BJ, Saxon A.
    J Occup Environ Med; 2003 May; 45(5):470-8. PubMed ID: 12762072
    [Abstract] [Full Text] [Related]

  • 5. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes.
    Ratnaseelan AM, Tsilioni I, Theoharides TC.
    Clin Ther; 2018 Jun; 40(6):903-917. PubMed ID: 29880330
    [Abstract] [Full Text] [Related]

  • 6. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
    Vojdani A, Campbell AW, Kashanian A, Vojdani E.
    Arch Environ Health; 2003 Jun; 58(6):324-36. PubMed ID: 14992307
    [Abstract] [Full Text] [Related]

  • 7. Health effects of mycotoxins in indoor air: a critical review.
    Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ.
    Appl Occup Environ Hyg; 2000 Oct; 15(10):773-84. PubMed ID: 11036728
    [Abstract] [Full Text] [Related]

  • 8. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
    Campbell AW, Thrasher JD, Madison RA, Vojdani A, Gray MR, Johnson A.
    Arch Environ Health; 2003 Aug; 58(8):464-74. PubMed ID: 15259425
    [Abstract] [Full Text] [Related]

  • 9. Environmental mold and mycotoxin exposures elicit specific cytokine and chemokine responses.
    Rosenblum Lichtenstein JH, Hsu YH, Gavin IM, Donaghey TC, Molina RM, Thompson KJ, Chi CL, Gillis BS, Brain JD.
    PLoS One; 2015 Aug; 10(5):e0126926. PubMed ID: 26010737
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings.
    Vojdani A, Thrasher JD, Madison RA, Gray MR, Heuser G, Campbell AW.
    Arch Environ Health; 2003 Jul; 58(7):421-32. PubMed ID: 15143855
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HLA gene variations and mycotoxin toxicity: Four case reports.
    Saghir SA, Ansari RA.
    Mycotoxin Res; 2024 Feb; 40(1):159-173. PubMed ID: 38198040
    [Abstract] [Full Text] [Related]

  • 14. Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure to molds compared to 100 exposed to chemicals.
    Kilburn KH.
    Toxicol Ind Health; 2009 Feb; 25(9-10):681-92. PubMed ID: 19793776
    [Abstract] [Full Text] [Related]

  • 15. The treatment of patients with mycotoxin-induced disease.
    Rea WJ, Pan Y, Griffiths B.
    Toxicol Ind Health; 2009 Feb; 25(9-10):711-4. PubMed ID: 19854821
    [Abstract] [Full Text] [Related]

  • 16. Mold and Mycotoxin Exposure and Brain Disorders.
    Ehsanifar M, Rajati R, Gholami A, Reiss JP.
    J Integr Neurosci; 2023 Oct 17; 22(6):137. PubMed ID: 38176924
    [Abstract] [Full Text] [Related]

  • 17. A critique of the ACOEM statement on mold: undisclosed conflicts of interest in the creation of an "evidence-based" statement.
    Craner J.
    Int J Occup Environ Health; 2008 Oct 17; 14(4):283-98. PubMed ID: 19043916
    [Abstract] [Full Text] [Related]

  • 18. Clinical reactivity to ingestion challenge with mixed mold extract may be enhanced in subjects sensitized to molds.
    Luccioli S, Malka-Rais J, Nsouli TM, Bellanti JA.
    Allergy Asthma Proc; 2009 Oct 17; 30(4):433-42. PubMed ID: 19772765
    [Abstract] [Full Text] [Related]

  • 19. Fungal exposure endocrinopathy in sinusitis with growth hormone deficiency: Dennis-Robertson syndrome.
    Dennis D, Robertson D, Curtis L, Black J.
    Toxicol Ind Health; 2009 Oct 17; 25(9-10):669-80. PubMed ID: 19808744
    [Abstract] [Full Text] [Related]

  • 20. Allergy and "toxic mold syndrome".
    Edmondson DA, Nordness ME, Zacharisen MC, Kurup VP, Fink JN.
    Ann Allergy Asthma Immunol; 2005 Feb 17; 94(2):234-9. PubMed ID: 15765738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.